The first biopharmaceutical drugs using complex organic molecules produced by genetically modified cells to deliver more efficient therapies have already started to write the next chapter of medicine. Treatments designed from lab-made versions of large proteins are now being used to treat cancers and autoimmune disorders like multiple sclerosis. Research shows they might also do well against infectious diseases.
The acquisition of Alstom’s energy assets delivered $1.5 billion in synergies in 2016, $300 million above GE’s original five-year target for Alstom synergies, GE’s Chief Financial Officer Jeff Bornstein told investors at a conference in New York held by GE’s Power and Renewable Energy businesses last week. “Alstom makes us more competitive,” Bornstein said. “It broadens the service base and creates long-term incremental value.”
tags
Erica Endicott was almost halfway through her first pregnancy and she was feeling great. When the date rolled around for the second trimester ultrasound — a routine test doctors use to check that everything is going according to plan — she and her husband, Nate, were excited. This is the test when parents get to see their baby’s face for the first time, walking away with incredible images they will treasure for the rest of their life.
The reason: Customers often needed to review and sign contracts more than 100 pages long before they could start doing business.